Matrix Metalloproteinase-14 Mediates a Phenotypic Shift in the Airways to Increase Mucin Production
Matrix Metalloproteinase 3
Matrix (chemical analysis)
Matrix metalloproteinase 9
DOI:
10.1164/rccm.200903-0328oc
Publication Date:
2009-08-07T01:43:17Z
AUTHORS (11)
ABSTRACT
Induced mainly by cigarette smoking, chronic obstructive pulmonary disease (COPD) is a global public health problem characterized progressive difficulty in breathing and increased mucin production. Previously, we reported that acrolein levels found COPD sputum could activate matrix metalloproteinase-9 (MMP9).To determine whether increases expression activity of MMP14, critical membrane-bound endopeptidase can initial MMP-activation cascade.MMP14 adduct formation were measured following direct treatment. MMP14 was human airway epithelial cells. immunohistochemistry performed with tissue, acrolein- or tobacco-exposed mice.In cell-free system, acrolein, concentrations equal to those sputum, directly adducted cysteine 319 the hemopexin-like domain activated MMP14. In cells, activity, which inhibited proprotein convertase inhibitor, hexa-d-arginine. epithelium subjects, immunoreactive protein increased. mouse lung, tobacco smoke lung protein. acrolein-induced transcripts an epidermal growth factor receptor (EGFR) neutralizing antibody, EGFR kinase metalloproteinase mitogen-activated (MAPK) 3/2 MAPK8 inhibitors, but not MAPK14 inhibitor. Decreasing vitro small interfering (si)RNA diminished MUC5AC transcripts. acrolein-exposed mice transgenic lung-specific transforming factor-alpha (an ligand) expression, these effects erlotinib.Taken together, findings implicate production COPD.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (97)
CITATIONS (45)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....